Buscar

Renown Health, the region's leading cardiology care provider, is offering a clinical trial for eligible patients struggling to control their high blood pressure. Nearly half of adults (119.9 million) in the United States have hypertension, or blood pressure that is higher than normal. Hypertension can put you at risk of other life-threatening disease, such as a heart attack or stroke. There are methods that cardiologists use to manage high blood pressure, but only 1 in 4 adults with hypertension (27.0 million) have their blood pressure under control.* Some patients with high blood pressure experience resistant hypertension, which does not respond well to multiple antihypertensive medications given at the same time. This means that there are many important opportunities for healthcare professionals to explore new ways to treat hypertension.  At Renown Health, we lead the region in cardiology care with our technological expertise and patient-centered approach. That is why our cardiology team is partnering with the Renown Research Office to offer the RADIANCE Continued Access Protocol (RADIENCE CAP) clinical trial to eligible patients. RADIANCE CAP is a non-randomized study designed to allow for continued access to ultrasound renal denervation therapy via the Paradise System, and to allow for the on-going collection of safety and effectiveness data in patients with uncontrolled hypertension despite the prescription of antihypertensive medications. The body’s complex communication system between the brain, heart and kidneys can sometimes become overactive, increasing your blood pressure through messages in the nervous system. Renal denervation is a minimally-invasive procedure which reduces activity from the nerves in your kidneys to lower blood pressure.  This is the third in a series of renal denervation clinical trials Renown Health has offered to patients with resistant hypertension over the last several years, with over 40 local participants.  “All the participants that I have had the pleasure to work with on these studies are very excited and grateful to have this option for helping control their blood pressure” states Lisa English, Lead Clinical Research Coordinator for Cardiology studies at Renown Health. “I love getting to know each one of them and helping on their healthcare journey. We have an amazing team of providers and staff at Renown that go out of their way to make patients experiences positive and the studies successful.” Dr. Michael Bloch, Cardiologist and Principal Investigator for the RADIANCE CAP study at Renown Health’s Institute for Heart and Vascular Health adds, “Despite lifestyle modifications like diet and exercise and the widespread availability of effective and well-tolerated medications, approximately 50% of all people with hypertension have inadequate blood pressure control putting them at risk for stroke, heart failure and kidney disease. As a one-time durable procedure, renal denervation with the Paradise endovascular system from ReCor Medical, Inc. may help millions of patients improve their blood pressure control without necessarily needing to increase their medications.” Our teams of expert providers and researchers are here to support you on your healthcare journey. Talk to your provider about the RADIANCE CAP clinical trial at your next appointment to see if participation may be right for you.

Read More About Managing Your Uncontrolled High Blood Pressure

In February, we think about hearts not just in honor of Valentine’s Day but because it is American Heart Association Month. This is a great reminder to focus on our personal cardiovascular health. Renown Health helps patients think about their heart health with our world-class providers and cutting-edge treatments through our Cardiovascular Clinical Trials. “Research serves a vital role in the future care of cardiovascular diseases. Being involved in research will help our medical community to further discover new treatment plans in our quest for life preservation and extension,” Dr. Thomas To, Cardiologist and Researcher at Renown Health. For example, let’s talk about atherosclerosis. When our hearts are healthy, they are a strong muscle that pumps our oxygen-rich blood through our coronary arteries. Over time, cholesterol and fats can build up in our arteries. This is a condition known as atherosclerosis. This type of plaque buildup in the arteries can lead to a heart attack or stroke if not properly managed. If you are experiencing chest pain or discomfort, shortness of breath or pain in areas of the upper body, these can be the warning signs of a heart attack, and you should call 911. One contributing factor to atherosclerosis is elevated lipoprotein(a) levels and the accumulation of cholesterol in the arteries, which increases the likelihood of a heart attack or stroke. Lipoprotein(a) is tested separately from the standard panel that is completed for cholesterol management, and while your total cholesterol levels may be in a healthy range, lipoprotein(a) levels can still be elevated. "Increasingly we are realizing that lipoprotein(a) levels can be used as an important assessment in more carefully delineating an individual's risk of future cardiovascular events and treatment targets" said Dr. Michael Bloch, Lipid Specialist and Researcher at Renown Institute for Heart and Vascular Health. While it is clear that elevated lipoprotein(a) contributes to atherosclerosis, there are currently no approved medications for reducing cardiovascular disease risk through reducing lipoprotein(a) levels. This is why Renown Health’s Research Office is proud to offer a phase III clinical trial, called the OCEAN(a) study, to our patients with elevated lipoprotein(a) levels as a care option for management of their heart disease risk. Our teams of expert providers and researchers are here to support you on your healthcare journey. “I am thrilled to be able to be part of this study and bring opportunities like this to our patients. The highlight of my day is getting to hear life stories from my patients during our study visits,” Lisa Preciado, Primary Clinical Research Coordinator for the OCEAN(a) study said. Join us in raising awareness around American Heart Month by talking to your provider about lipoprotein(a) at your next appointment. At Renown Health, our goal is to make it easy for patients to access clinical research as a care opportunity where patients can access a variety of standard care treatment options for their health condition or choose to participate in a clinical trial. For more information about clinical trial opportunities available to you or to ask any questions, contact the Renown Research Office at Renown-CRD@renown.org or 775-982-3646.

Read More About Getting to the HEART of Research

Meet a couple that's all heart. After each had a heart attack one year apart, they committed to Renown's new Healthy Heart Program and support each other along the road to heart health. Almost a year to the day that Janis VanHorn had a heart attack, her partner, Carl Edson, had one too.  "That kind of doubled the dose of making sure that we were doing everything that we could to continue with our life," VanHorn says. "It's a very life-altering thing.” And after Edson's quadruple bypass open heart surgery, he was grateful for the simple act of getting into the car with the woman he loves. "I was so relieved," he says. "I didn't realize how precious life was until that moment." The couple see the same cardiologist, Richard Seher, M.D., FACC, FSCAI, who recommended they participate in Renown's new Healthy Heart Program, a 12-week, 36-visit intensive cardiac rehabilitation curriculum that includes monitored exercising and cooking classes. Now they're both familiar faces at the program, which is located at the Renown South Meadows Medical Center. After several weeks, Edson says he has lost 10 pounds and VanHorton has lost inches and feels more toned. Tackling the program together has brought the couple closer and given them the opportunity to fuel one another's health goals and longevity. "I would be lost without this man," VanHorn says," and anything I can do to help him live longer, I'm going to do that." Edson adds, "She is to me my whole life, and I mean that sincerely. There's no one else I can turn to that has helped me in my life as she has, and I'm just trying to return the favor in a big-time way. She is my everything."

Read More About Carl and Janis Team Approach to Renowns Healthy Heart Program

When lifelong trekker and adventurer Dorismae Weber learned her aortic valve was shutting down, she was afraid she was losing something she loved most: her daily walks. But following a trans catheter aortic valve implantation, Weber reclaimed her walking shoes — and her life. This is her story. An avid walker and traveler, Dorismae Weber’s life changed dramatically when she was exploring Mongolia and began having trouble breathing. Weber, 84, learned her aortic valve was shutting down. “It’s scary when you lose what you’ve always done,” Weber says. “I’ve walked all my life, and it’s always been the place I’ve gone to for comfort, for solving problems, for just enjoying. But all of a sudden, I couldn’t do this anymore.” Weber was not a candidate for traditional open heart surgery because she had heart surgery in the past. Then Weber learned about about trans catheter aortic valve implantation, also known as TAVR. She went to see Renown cardiologist Jake Ichino, MD, who put her through a battery of tests before performing the procedure. “Unlike the standard traditional open heart surgery, TAVR is a less invasive approach,” Dr. Ichino says. “We traditionally go up the artery of the leg with a catheter tube device and then we implant a valve without opening the chest.” After the TAVR procedure, Weber was once again able to complete her daily five-mile hikes. “When I woke up, all I can tell you is that I looked around and I thought, ‘I have a whole new life ahead of me — when I was told there was very little left,'” Weber says. She has also planned a trek just below the arctic circle with the environmental group Earthwatch. “I’m here because I had that procedure,” Weber says. “I’m here because they offered that procedure. And I’m very grateful for it, because I wouldn’t be here without it.” To learn more about TAVR, visit Renown’s Institute for Heart and Vascular Health.

Read More About How Dorismae Reclaimed Her Life and Walking Shoes with TAVR